Jack Mouhanna

Safety and Efficacy of Nanomicellar 0.09% Cyclosporine for Treatment of Dry Eye Disease Refractory to 0.05% Cyclosporine Emulsion: A Single-Arm Prospective Switch Study

Cornea · 2026

Staged surgical and optical rehabilitation after bilateral corneoscleral melt from hyperacute gonococcal keratoconjunctivitis

Letter or commentary · Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie · 2026